Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2023-11-09 Board/Management Inform…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
ResMed Adopts New Operating Model 5 pages 69.1KB
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated November 9, 2023, by ResMed Inc. The content focuses on organizational changes including the retirement of the COO and president, appointment of new executive officers, and changes in the operating model. It includes detailed descriptions of leadership transitions and new roles, as well as a press release attached as Exhibit 99.1. There are no financial statements or financial performance data included. The primary subject is changes in the company's board of directors or senior management. Therefore, this document fits the category of Board/Management Information (MANG). The document length is over 10,000 characters, indicating it is not a brief announcement but a full report of management changes.
2023-11-09 English
Update - Dividend/Distribution - RMD 4 pages 26.1KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Notification of dividend / distribution' and provides detailed information about a dividend payment, including the dividend amount, record date, payment date, currency, withholding tax rates, and updates to a previous announcement. It specifically discusses dividend details for holders of Chess Depositary Instruments (CDIs) and includes exchange rate information relevant to the dividend payment. There is no indication that this is a full financial report or earnings release; rather, it is an announcement focused solely on dividend details. Therefore, the document fits the category of 'Notice of Dividend Amount' (DIV). The document length and content confirm it is a substantive announcement, not just a brief note or a report publication announcement.
2023-11-09 English
Statement of CDIs on issue - RMD 4 pages 22.6KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Statement of CDIs on Issue' and provides detailed information about the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes data for a specific month (October 2023) and discusses changes in securities, transfers, and new shares issued under employee plans. The content focuses on share capital and securities issued rather than financial performance, management changes, or regulatory announcements. The document length is 3082 characters, which is relatively short but contains substantive data about securities issued. This fits the definition of a Share Issue/Capital Change announcement, which covers new share issues, stock splits, or other capital changes. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2023-11-02 English
FORM 10Q for Qtr ended September, 2023 37 pages 458.4KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-Q' and is a quarterly report pursuant to the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2023. It contains detailed unaudited condensed consolidated financial statements including balance sheets, statements of operations, comprehensive income, changes in equity, and cash flows. It also includes management's discussion and analysis, legal proceedings, risk factors, and other substantive financial data. The length of the document is 15,000 characters, indicating it is a full report rather than a brief announcement. The presence of detailed financial statements and analysis confirms this is an Interim / Quarterly Report. Q1 2024
2023-10-29 English
ResMed Announces Results for the First Quarter of FY2024 10 pages 147.5KB
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement of ResMed Inc.'s financial results for the first quarter of fiscal year 2024, including revenue, profit, earnings per share, and other financial metrics. It contains unaudited condensed consolidated statements of operations, balance sheets, and cash flows, all for the quarter ended September 30, 2023. The document also includes management commentary on the results, business highlights, dividend declaration, and webcast details for an earnings call. The presence of comprehensive financial data and analysis for a fiscal quarter, along with the date and period specified, clearly identifies this as an Interim / Quarterly Report. It is not merely a brief earnings release or a regulatory announcement; it contains substantive financial statements and discussion. Therefore, the correct classification is Interim / Quarterly Report (IR). Q1 2024
2023-10-26 English
Dividend/Distribution - RMD 4 pages 25.0KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Notification of dividend / distribution' and contains detailed information about the dividend amount, ex-date, record date, payment date, currency, withholding tax rate, and other dividend-related specifics. It is clearly an announcement regarding the dividend payment for a specific quarter ending 30/9/2023. The content matches the definition of a Notice of Dividend Amount, which includes dividend amounts, payment dates, and details for shareholders. The document length is 4522 characters, which is sufficient to provide substantive dividend details rather than just a brief mention or a report publication announcement. Therefore, the appropriate classification is 'DIV' for Notice of Dividend Amount.
2023-10-26 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.